Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
Published in Eye Care

Journal Scan / Research · August 24, 2024

Association Between Time to Initiate Anti-VEGF Therapy and Visual Outcomes in Central Retinal Vein Occlusion

Scientific Reports

 

Additional Info

Scientific Reports
Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion
Sci Rep 2024 Jul 23;14(1)16974, C Agata, S Aoki, K Kitamoto, K Azuma, R Fujino, T Inoue, R Obata

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading